论文部分内容阅读
目的分析评价后腹腔镜肾癌根治术对于T2期肾癌的临床治疗价值。方法选取我院2012年1月~2013年2月收治的66例T2期肾癌患者,根据患者施术方式的不同分为两组,观察组33例采用后腹腔镜肾癌根治术,对照组33例采用开放性肾癌根治术。对比两组手术时间、术中出血量、术后并发症及生存率等资料。结果观察组患者平均手术时间为(183±29)min,对照组患者为(162±24)min,观察组手术时间高于对照组,其差异具有统计学意义(P<0.05);观察组患者术中出血量为(276±203)ml,对照组为(443±237)ml;观察组患者住院天数为(8.7±1.0)d,对照组为(11.3±2.2)d;观察组在术中出血量、住院天数方面均显著由于对照组,其差异具有统计学意义(P<0.05)。结论后腹腔镜肾癌根治术在治疗T2期肾癌的临床疗效显著,且安全性高,值得临床推广。
Objective To evaluate the clinical value of retroperitoneal laparoscopic radical nephrectomy for stage T2 renal cell carcinoma. Methods Sixty-six patients with stage T2 renal cell carcinoma admitted to our hospital from January 2012 to February 2013 were divided into two groups according to the different operation modes. The observation group received retroperitoneal laparoscopic radical nephrectomy and the control group Thirty-three patients underwent open radical nephrectomy. The operation time, intraoperative blood loss, postoperative complications and survival rate were compared between the two groups. Results The average operation time in the observation group was (183 ± 29) min and in the control group was (162 ± 24) min. The observation group had a higher operation time than the control group (P <0.05) The intraoperative blood loss was (276 ± 203) ml in the control group and (443 ± 237) ml in the control group, and (8.7 ± 1.0) days in the observation group and (11.3 ± 2.2) days in the control group, respectively The amount of bleeding and length of hospital stay were significantly different in the control group (P <0.05). Conclusions Retroperitoneal laparoscopic radical nephrectomy in the treatment of T2 stage renal cell carcinoma has significant clinical efficacy and high safety, which is worthy of clinical promotion.